Metabolic and cardiovascular effects of early insulin glargin prescription: based on data from ORIGIN study
We discuss results of ORIGIN, a multicenter parallel groups study for efficiency assessment of insulin glargin against polyunsaturatedomega-3 fatty acids or placebo regarding cardiovascular and/or mortality risk reduction in patients with impaired fasting glycemia,impaired glucose tolerance or type...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2012-09-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://www.dia-endojournals.ru/jour/article/view/6092 |